The present disclosure relates generally to ophthalmic lenses, and more specifically to a novel double-sided aspheric diffractive multifocal lens, design, manufacture, and uses thereof.
Ophthalmology is the field of medicine directed to the anatomy, physiology and diseases of the human eye. The anatomy of the human eye is rather complex. The main structures of the eye include the cornea, a spherical clear tissue at the outer front of the eye; the iris, which is the colored part of the eye; the pupil, an adaptable aperture in the iris that regulates the amount of light received in the eye; the crystalline lens, a small clear disk inside the eye that focuses light rays onto the retina; the retina is a layer that forms the rear or backside of the eye and transforms sensed light into electrical impulses that travel through the optic nerve to the brain. The posterior chamber, i.e., the space between the retina and the lens, is filled with aqueous humour, and the anterior chamber, i.e., the space between the lens and the cornea, is filled with vitreous humour a clear, jelly-like substance.
The natural crystalline lens has a flexible, transparent, biconvex structure, and together with the cornea, operates to refract light to be focused on the retina. The lens is flatter on its anterior side than on its posterior side and its curvature is controlled by the ciliary muscles to which the lens connects by suspensory ligaments, called zonules. By changing the curvature of the lens, the focal distance of the eye is changed so as to focus on objects at various distances. To view an object at a short distance from the eye, the ciliary muscles contract, and the lens thickens, resulting in a rounder shape and thus high refractive power. Changing focus to an object at a greater distance requires the relaxation of the lens and thus increasing the focal distance. This process of changing curvature and adapting the focal distance of the eye to form a sharp image of an object at the retina is called accommodation.
In humans, the refractive power of the crystalline lens in its natural environment is approximately 18-20 diopters, roughly one-third of the total optical power of the eye. The cornea provides the remaining 40 diopters of the total optical power of the eye.
With the ageing of the eye, the opaqueness of the lens diminishes, called a cataract. Some diseases like diabetes, trauma, some medications, and excessive UV light exposure may also cause a cataract. A cataract is painless and results in a cloudy, blurry vision. Treatments for cataracts include surgery, by which the cloudy lens is removed and replaced with an artificial one, generally called an intraocular lens (IOL or IOLs).
Another age-related effect is called presbyopia, which is manifested by difficulty in reading small print or seeing nearby pictures clearly. Presbyopia generally is believed to be caused by a thickening and loss of flexibility of the natural lens inside the eye. Age-related changes also take place in the ciliary muscles surrounding the lens. With less elasticity it becomes harder to focus at objects close to the eye.
A variety of intraocular lenses are also employed for correcting other visual disorders, such as myopia or nearsightedness, when the eye is unable to see distant objects caused by the cornea having too much curvature, for example. The effect of myopia is that distant light rays focus at a point in front of the retina, rather than directly on its surface. Hyperopia or farsightedness, caused by an abnormally flat cornea, such that light rays entering the eye focus behind the retina, not allowing to focus on objects that are close, and astigmatism, which is another common cause of visual difficulty in which images are blurred due to an irregularly shaped cornea.
In the majority of cases, intraocular lenses are implanted in a patient's eye during cataract surgery, to replace the natural crystalline lens and compensate for the loss of optical power of the removed lens. Modern IOL optics are designed to have a multifocal optic for providing short, intermediary and distance vision of objects, also called multifocal IOL, or more specific trifocal lenses. Presbyopia is corrected by eyeglasses or contact lenses and patient's may also opt for multifocal optics. In some cases, an IOL can include diffractive structures to have not only a far-focus power but also a near-focus power, thereby providing a degree of pseudo-accommodation. However, a variety of aberrations, such as spherical and astigmatic aberrations, can adversely affect the optical performance of such lenses. For example, spherical aberrations can degrade vision contrast, especially for large pupil sizes.
Accordingly, what is needed is intraocular lenses that can simultaneously provide a near focus, an intermediate focus, and a distance focus, which can also address adverse effects such as spherical and astigmatic aberrations, thereby providing enhanced contrast and improved visual acuity.
The present disclosure is related to a double-sided aspheric diffractive multifocal lens, which can eliminate spherical and astigmatic aberrations and provide enhanced contrast and improved visual acuity. In some embodiments, the diffractive multifocal lens can include a lens body, the lens body can include: a first aspheric surface; and a second aspheric surface including a central zone and a plurality of diffractive elements comprising concentric annular zones extending in a radial direction, each concentric annular zone having a periodically structured curve comprising two smooth turning points between two sharp turning points, thereby producing a near focus (f2), an intermediate focus (f1), and a distance focus (f0).
In some embodiments, the first aspheric surface is anterior surface, and the second aspheric surface is posterior surface. In some embodiments, the first aspheric surface can include a toric component. In some embodiments, a height profile of the first aspheric surface and/or the second aspheric surface is represented by:
wherein Zasp is the height profile of the aspheric structure, r is the radial distance in millimeters, c is the curvature, k is the conic constant, and Ai is high order aspheric coefficients.
In some embodiments, a height profile of the diffractive elements is represented by:
wherein λ is the design wavelength, Φ(n)(r) is phase profile, n1 is refractive index of lens material, and n0 is refractive index of a medium covering the lens.
In some embodiments, phase profile Φ(n)(r) can be represented as:
wherein r is the radial distance of the lens in millimeter, rn is radius of nth zone, rn+1 is radius of (n+1)th zone, and A, B, C and D, are light distribution parameters. A is amplitude; B is the period as
C is phase shift; D is vertical shift.
In some embodiments, phase profile Φ(n)(r) can be in the range of −4π≤Φ(n)(r)≤4π. In some embodiments, the distance focus (f0), the intermediate focus (f1), and the near focus (f2) are in the range of:
In some embodiments, the diffractive multifocal lens can be an intraocular lens (IOL). In some embodiments, the diffractive multifocal lens can further include a pair of haptics extended outwardly from the lens body. In some embodiments, the IOL is a posterior chamber IOL, and the posterior chamber IOL is configured to be implanted into capsular bag of a human eye.
In some embodiments, the present disclosure is directed to a method of treating an ophthalmic disease or disorder in a subject, the method can include implanting into an eye of the subject a diffractive multifocal lens comprising a lens body, the lens body can include a first aspheric surface; and a second aspheric surface comprising a central zone and a plurality of diffractive elements comprising concentric annular zones extending in a radial direction, each concentric annular zone having a periodically structured curve comprising two smooth turning points between two sharp turning points.
In some embodiments, the present disclosure is directed to a method of manufacturing a diffractive multifocal lens, the method can include (a) manufacturing a first aspheric surface optionally comprising a toric component; (b) manufacturing a second aspheric surface; and (c) generating a central zone and diffractive elements comprising a plurality of concentric annular zones on the second aspheric surface, each concentric annular zone having a periodically structured curve comprising two smooth turning points between two sharp turning points, thereby producing a near focus (f2), an intermediate focus (f1), and a distance focus (f0). In some embodiment, the method can further include performing an in situ image quality analysis to ensure the performance meets the pre-established quality criteria.
The present disclosure is related to a double-sided aspheric diffractive multifocal lens and methods of designing and manufacturing of such lenses in the field of ophthalmology. The lens can include an aspheric anterior surface and an aspheric posterior surface. One of the two surfaces can include a plurality of concentric diffractive multifocal zones. The other surface can optionally include a toric component. The double-sided aspheric surface design results in an improvement of the modulation transfer function (MTF) of the lens-eye combination by aberration reduction and vision contrast enhancement as compared to one-sided aspheric lens. The surface having a plurality of concentric diffractive multifocal zones can produce a near focus, an intermediate focus, and a distance focus.
Multifocal IOLs are commonly used to treat presbyopia, a condition in which the eye exhibits a progressively diminished ability to focus on near objects. Human beings become presbyopic due to aging, and the effect typically becomes noticeable starting at about the age of 40-45 years old, when they discover they need reading glasses. Presbyopic individuals who wear corrective lenses may then find that they need two separate prescriptions, preferably within the same bifocal lens, one for reading (near) and another for driving (distance). A trifocal lens can further improve vision at intermediate distances, for example, when working at a computer.
Diffractive IOLs can have a repeating structure that may be formed in the surface of an optical element by a fabrication method such as, for example, cutting the surface using a lathe that may be equipped with a cutting head made of a hard mineral such as diamond or sapphire; direct write patterning using a high energy beam such as a laser beam or electron beam or a similar method of ablating the surface; etching the surface using a photolithographic patterning process; or molding the surface. The diffractive structure is typically a series of concentric annular zones, which requires each zone to become progressively narrower from the center to the edge of the lens. There may be, for example, about 5 to 30 zones between the center and the edge of the lens. The surface profile within each zone is typically a smoothly varying function such as an arc, a parabola, or a line. At the outer periphery of each zone there is a discrete step in the vertical surface profile. The resulting surface structure can act as a circularly symmetric diffraction grating that disperses light into multiple diffraction orders, each diffraction order having a consecutive number, zero, one, two, three and so forth.
Diffractive IOLs lenses may be used for correcting presbyopia. In such an application, the lens can include one refractive surface and one diffractive surface. In practice, the light energy passing through a diffractive lens is typically concentrated into one, two, or three diffractive orders, while contributing an insignificant amount of light energy to other diffractive orders.
Existing designs for multifocal IOLs use either refractive optics, a combination refractive/diffractive design, or diffractive lenses that direct light into a single diffractive order. However, the fabrication of such IOLs can be time-consuming and expensive. Therefore, there is a need for improved ophthalmic lenses, particularly for improved diffractive IOLs that can be more readily fabricated.
The present disclosure is directed to an intraocular lens (IOL), which provides an extended vision range.
In some embodiments, lens body 101 can take the shape of biconvex shape. Other shapes of lens body 101 can include, but are not limited to, plano-convex, biconcave, plano-concave shape, or combinations of convex and concave shapes. In some embodiments, both anterior surface 108 and posterior surface 109 can feature an aspheric structure, providing a double-sided asphericity for IOL 100.
Diffractive element 104 can include diffractive rings or steps or also known as diffractive zones having a characteristic radial separation to produce constructive interference at characteristic foci on the optic area of the IOL. In some embodiments, diffractive elements 104 can include about 3 to about 30 diffractive rings/zones. In some embodiments, diffractive elements 104 can include about 5, 10, 15, 20, or 25 diffractive rings/zones. The IOL can contain diffractive elements on one of the surfaces or both surfaces of the lens. In some embodiments, the diffractive elements 104 can be placed on the posterior surface of the IOL. In some embodiments, the diffractive elements can be placed at the posterior surface, because there is less light scattering effect at the posterior surface than at the anterior surface. The plurality of diffractive elements 104 can include rings or zones extending concentrically with respect to the optical axis 105 through the central zone 103 over at least part of the posterior surface 109 of the lens body 101. The diffraction elements 104 can provide a focal point of far, intermediate, and/or near distance. In some embodiments, diffraction elements 104 are not limited to concentric circular or annular ring-shaped zones, but can include concentric elliptic or oval shaped zones.
In some embodiments, the optic diameter 106 of lens body 101 can be about 4 to about 8 mm, while the total outer diameter 107 of IOL 100 including the haptics 102 can be about 9 to about 18 mm. Lens body 101 can have a center thickness 110 of about 0.8 to about 1.2 mm. Although the embodiment in
The amount of correction that an ophthalmic lens provides is called optical power, and is expressed in Diopter (D). The optical power is calculated as the inverse of a focal distance f measured in meters, which can be a respective focal distance from the lens to a respective focal point for far, intermediate, or near vision. Lens body 101 in the double-sided aspheric shape of the present disclosure can provide a base optical power of about 10 to about 25 D. In some embodiments, lens body 101 can provide a base optical power of about 12, 14, 16, 18, 20, 22, or 24 D. The plurality of diffractive elements 104 can provide added power of f1=f0+2.2D and f2=f0+3.3D.
IOLs can be made of flexible material which permits a reduction of their overall apparent girth by temporary deformation, facilitating their insertion through the cornea, thereby advantageously enabling the use of a corneal incision of concomitantly reduced size. In some embodiments, the lens body can include polypropylene, polycarbonate, polyethylene, acryl-butadiene styrene, polyamide, polychlorotrifluoroethylene, polytetrafluoroethylene, polyvinyl chloride, polyvinylidene fluoride, polyvinylchloride, polydimethylsiloxane, polyethylene terephthalate, ethylene tetrafluoroethylene, ethylene chlorotrifluoroethylene, perfluoroalkoxy, polymethylpentene, polymethylmethacrylate, polystyrene, polyetheretherketone, tetrafluoroethylene, polyurethane, poly(methyl methacrylate), poly (2-hydroxyethyl methacrylate), nylon, polyether block amide, silicone or a mixture thereof.
In some embodiments, the lens body can include a hydrophilic polymer made of monomers selected from the group consisting of: 2-acrylamido-2-methylpropane sulfonic acid, 2-hydroxyethyl methacrylate, N-vinylpyrrolidone, vinylbenzyltrimethyl ammonium salt, diethylaminoethyl methacrylate, dimethylaminoethyl acrylate, dimethylaminoethyl methacrylate, diethyl aminoethyl acrylate, diethylaminomethyl methacrylate, tertiary butylaminoethyl acrylate, tertiary-butylaminoethyl methacrylate and dimethylaminopropylacrylamide, acrylic acid, methacrylic acid, styrenesulfonic acid and salts thereof, hydroxypropyl acrylate, vinylpyrrolidone, dimethylacrylamide, ethylene glycol monomethacrylate, ethylene glycol monoacrylate, ethylene glycol dimethacrylate, ethylene glycol diacrylate, triethylene glycol diacrylate and triethylene glycol methacrylate. In some embodiments, these hydrophilic monomers are surface grafted onto the polymeric matrix in the previous paragraph to make the lens body. In some embodiments, the IOL of the present disclosure can be made of polymeric compositions according to U.S. Pat. No. 10,494,458, which is incorporated herein by reference in its entirety.
The haptics of the IOL according to the present disclosure can be made of polymeric materials including, but not limited to polymethacrylate, polypropylene, polyethylene, polystyrene, and polyacrylate.
The surface of the IOL can include a spheric, aspheric, or toric element. Spheric surfaces can cause spherical aberration, which is a type of optical imperfection that can cause increased glare, and reduced overall quality of vision especially in low light and darkness. Aspheric lenses can correct spherical aberration. Aspherical IOL can provide improved contrast sensitivity, enhanced functional vision and superior night driving ability.
A toric element is typically used for astigmatic eye correction. Generally, astigmatism is an optical defect in which vision is blurred due to the ocular inability to focus a point object into a sharply focused image on the retina. This may be due to an irregular curvature of the cornea and/or lens. The refractive error of the astigmatic eye stems from a difference in degree of curvature, and therefore in degree of refraction, of the different meridians of the cornea and/or the crystalline lens, which causes the eye to have two focal points, one correspondent to each meridian. As used herein, a meridian includes one of two axes that subtend a curved surface, such as the prime meridian on the earth, for example. Meridians may be orthogonal. By way of example, the meridians of the earth may be any orthogonal line of longitude and any line of latitude that curve about the surface of the earth.
For example, in an astigmatic eye, an image may be clearly focused on the retina in the horizontal (sagittal) plane, but may be focused behind the retina in the vertical (tangential) plane. In the case where the astigmatism results only from the cornea, the two astigmatism meridians may be the two axes of the cornea. If the astigmatism results from the crystalline lens, the two astigmatism meridians may be the two axes of the crystalline lens. If the astigmatism results from a combination of the cornea and the crystalline lens, the two astigmatism meridians may be the respective axes of the combined lenses of the cornea and the crystalline lens.
An astigmatism arising from the cornea or crystalline lens, or the combination of the two lenses, may be corrected by a lens including a toric component. A toric surface resembles a section of the surface of a football, for which there are two regular radii of curvature, one smaller than another. These radii may be used to correct the defocus in the two meridians of the astigmatic eye. Thus, blurred vision caused by astigmatism may be corrected by corrective lenses or laser vision correction, such as glasses, hard contact lenses, contact lenses, and/or an IOL, providing a compensating optic specifically rotated around the optical axis.
In some embodiments, the IOL according to the present disclosure can provide far vision for viewing objects at distances ranging from about infinity to about 4 meters (m). In some embodiments, the IOL of the present disclosure can provide near vision for viewing objects at distances less than about 0.4 m. In some embodiments, the IOL of the present disclosure can provide intermediate vision for viewing objects at distances in a range of about 0.4 to about 1 m, about 2 m, about 3 m, or about 4 m. As a result, the IOL of the present disclosure can advantageously provide a degree of accommodation for different distance ranges, typically referred to as pseudo-accommodation. In some embodiments, when implanted into a patient's eye, the combined power of the eye's cornea and the near, intermediate, and far power of the IOL of the present disclosure can allow focusing light emanating from objects within a near, an intermediate, and a far distance range of the patient onto the retina. In some embodiments, the distance focus (f0), intermediate focus (f1), and near focus (f2) provided by the IOL of the present disclosure can have the following ranges:
This diffractive structure embodied on the IOLs of the present disclosure can be designed using Equations (I) to (IV) as discussed below.
Pupil Function. A pupil function is a lens characteristic function that describes the physical effect of a lens by which it is possible to change the state of light made incident on the lens, and in specific terms, is represented by the product of the amplitude function A(r) and the exponential function of the phase function Φ(n)(r) as noted in Equation (I) below.
T(r)=A(r)ei(Φ
Phase Function. A phase function is defined as the function that mathematically expresses the physical effect provided in a lens such as giving changes in the phase of incident light on a lens (position of wave peaks and valleys) using any method. The variable of the phase function is mainly expressed by position r in the radial direction from the center of the lens, and the phase of light made incident on the lens at the point of the position r undergoes a change by the phase function Φ(n)(r) and is emitted from the lens. In specific terms, this is represented by an r-Φ coordinate system. In the present disclosure, phase is noted as Φ, and the unit is radians. One wavelength of light is represented as 2π radians, and a half wavelength as π radians, for example. A distribution of phase in the overall area in which the phase function is provided expressed in the same coordinate system is called a phase profile, or is simply called a profile or zone profile. With an r axis of Φ=0 as a reference line, this means that the light made incident at the point of Φ=0 is emitted without changing the phase. Also, for this reference line, when a positive value is used for Φ, this means that progress of the light is delayed by that phase amount, and when a negative value is used for Φ, this means that progress of the light is advanced by that phase amount. In an actual ophthalmic lens, a refracting surface for which a diffractive structure is not given corresponds to this reference line (surface). Light undergoes a phase change based on this phase function and is emitted from the lens.
Amplitude Function. An amplitude function is the function expressed by A(r) in Equation (I) noted above. In the present disclosure, this is defined as a function that represents the change in the light transmission amount when passing through a lens. The variable of the amplitude function is represented as position r in the radial direction from the center of the lens, and represents the transmission rate of the lens at the point of position r. Also, the amplitude function is in a range of 0 or greater and 1 or less, which means that light is not transmitted at the point of A(r)=0, and that incident light is transmitted as it is without loss at the point of A(r)=1.
Zone. In the present disclosure, a zone is used as the minimum unit in a diffractive structure, element, or diffraction grating provided in a lens.
The height profile of the diffractive structure (Zdiff) on the IOL can be calculated based on Equation (II) below.
The radius of a particular diffractive zone (rn) can be calculated based on Equation (III) below.
rn=√{square root over (2×λ×n×f)} Equation (III)
Phase function (Φ(n)(r)) can be calculated via Equation (IV) below.
The double-sided aspheric structure (anterior and posterior of the optic area of the IOL) is for the correction of the spherical aberration of the lens. The height profile of the aspheric base structure (Zasp) of the lens can be calculated according to the following Equation (V):
When both aspheric and diffractive structures are placed onto the same surface (anterior surface and/or posterior surface of the IOL), according to some embodiments of the present disclosure, the height profile of the combination structure (Ztotal) will be the summation of the height profile of the aspheric structure (Zasp) and the height profile of the diffractive structure (Zdiff), as calculated according to the below Equation (VI).
Ztotal(r)=Zasp(r)+Zdiff(r) Equation (VI)
In some embodiments, the above-described lens can be contact lens or IOL. In some embodiments, the IOL can be intracorneal IOL, anterior chamber IOL or posterior chamber IOL. In some embodiments, the IOL can be posterior chamber IOL. While the haptic arms are illustrated in the embodiment, any suitable haptics fixation structure for the capsular bag or the ciliary sulcus compatible with posterior chamber implantation can also be used in a posterior chamber IOL.
A way of estimating the optical priority of an intraocular lens comprises determining experimentally its modulation transfer function (MTF). The MTF of an optical system can be measured according to Annex C of ISO 11979-2, which reflects the proportion of the contrast which is transmitted through the optical system for a determined spatial frequency of a test pattern, which frequency is defined as “cycles/mm” or “LP/mm”, in which “LP” indicates “line pairs.” Generally, the contrast decreases with an increase in spatial frequency.
All publications, patents, and patent applications mentioned in the present disclosure are herein incorporated by reference to the same extent as if each individual publication, patent, or patent application was specifically and individually indicated to be incorporated by reference.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs. Although any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the disclosure, it will be understood that modifications and variations are encompassed within the spirit and scope of the instant disclosure. The preferred methods and materials are now described.
Presented below are examples discussing different embodiments of the IOLs contemplated for the discussed applications. The following examples are provided to further illustrate the embodiments of the present disclosure, but are not intended to limit the scope of the disclosure. While they are typical of those that might be used, other procedures, methodologies, or techniques known to those skilled in the art may alternatively be used.
From Equation (IV), by varying parameters A, B, C and D, and controlling the distance focus (f0), the intermediate focus (f1), and the near focus (f2), the optical performance (modulation transfer function, MTF) at a 3 mm aperture and at a resolution measurement of 50 line pairs per millimeter (LP/mm) is shown in
The curve in
The Ztotal(r) height profile of the aspheric and diffractive combination structure is shown in
From Equation (IV), by varying parameters A, B, C and D, and controlling the f0, f1 and f2, the optical performance (MTF) at a 3 mm aperture and at a resolution measurement of 50 line pairs per millimeter (LP/mm) is shown in
The curve in
From Equation (IV), by varying parameters A, B, C and D, and controlling the f0, f1 and f2, the optical performance (MTF) at a 3 mm aperture and at a resolution measurement of 50 line pairs per millimeter (LP/mm) is shown in
The curve in
While the disclosure has been particularly shown and described with reference to specific embodiments, it should be understood by those having skill in the art that various changes in form and detail may be made therein without departing from the spirit and scope of the present disclosure as disclosed herein.
All references referred to in the present disclosure are hereby incorporated by reference in their entirety. Various embodiments of the present disclosure may be characterized by the potential claims listed in the paragraphs following this paragraph (and before the actual claims provided at the end of this application). These potential claims form a part of the written description of this application. Accordingly, subject matter of the following potential claims may be presented as actual claims in later proceedings involving this application or any application claiming priority based on this application. Inclusion of such potential claims should not be construed to mean that the actual claims do not cover the subject matter of the potential claims. Thus, a decision to not present these potential claims in later proceedings should not be construed as a donation of the subject matter to the public.
The embodiments of the disclosure described above are intended to be merely exemplary; numerous variations and modifications will be apparent to those skilled in the art. All such variations and modifications are intended to be within the scope of the present disclosure as defined in any appended claims.
The application claims benefit of priority under 35 U.S.C. § 119(e) of U.S. Ser. No. 63/032,892, filed Jun. 1, 2020, the entire content of which is incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
2163130 | Pellow | Jun 1939 | A |
4402579 | Poler | Sep 1983 | A |
4450593 | Poler | May 1984 | A |
4466858 | Poler | Aug 1984 | A |
4473434 | Poler | Sep 1984 | A |
4619657 | Keates et al. | Oct 1986 | A |
4720286 | Bailey et al. | Jan 1988 | A |
4846913 | Frieder et al. | Jul 1989 | A |
4955904 | Atebara et al. | Sep 1990 | A |
4981342 | Fiala | Jan 1991 | A |
4995714 | Cohen | Feb 1991 | A |
4995715 | Cohen | Feb 1991 | A |
5017000 | Cohen | May 1991 | A |
5037485 | Chromecek et al. | Aug 1991 | A |
5044743 | Ting | Sep 1991 | A |
5073021 | Marron | Dec 1991 | A |
5106180 | Marie et al. | Apr 1992 | A |
5121979 | Cohen | Jun 1992 | A |
5142411 | Fiala | Aug 1992 | A |
5144483 | Cohen | Sep 1992 | A |
5158572 | Nielsen | Oct 1992 | A |
5257132 | Ceglio et al. | Oct 1993 | A |
5278592 | Marie et al. | Jan 1994 | A |
5331394 | Shalon et al. | Jul 1994 | A |
5344447 | Swanson | Sep 1994 | A |
5410375 | Fiala | Apr 1995 | A |
5517260 | Glady et al. | May 1996 | A |
5623322 | Hirschman et al. | Apr 1997 | A |
5682223 | Menezes et al. | Oct 1997 | A |
5718849 | Maus et al. | Feb 1998 | A |
5750060 | Maus et al. | May 1998 | A |
5750156 | Maus et al. | May 1998 | A |
5760871 | Kosoburd et al. | Jun 1998 | A |
5782911 | Herrick | Jul 1998 | A |
5806530 | Herrick | Sep 1998 | A |
5821943 | Shashua | Oct 1998 | A |
5838496 | Maruyama | Nov 1998 | A |
5855605 | Herrick | Jan 1999 | A |
5861934 | Blum et al. | Jan 1999 | A |
5875017 | Ohnuma et al. | Feb 1999 | A |
5968094 | Werbin et al. | Oct 1999 | A |
5982543 | Fiala | Nov 1999 | A |
6010215 | Miceli | Jan 2000 | A |
6024902 | Maus et al. | Feb 2000 | A |
6068464 | Su et al. | May 2000 | A |
6082987 | Su et al. | Jul 2000 | A |
6086203 | Blum et al. | Jul 2000 | A |
6099763 | Su et al. | Aug 2000 | A |
6103148 | Su et al. | Aug 2000 | A |
6106118 | Menezes et al. | Aug 2000 | A |
6123422 | Menezes et al. | Sep 2000 | A |
6139145 | Israel | Oct 2000 | A |
6139148 | Menezes | Oct 2000 | A |
6149271 | Menezes et al. | Nov 2000 | A |
6199984 | Menezes | Mar 2001 | B1 |
6231184 | Menezes et al. | May 2001 | B1 |
6288846 | Stoner, Jr. | Sep 2001 | B1 |
D449321 | Su | Oct 2001 | S |
6312424 | Largent | Nov 2001 | B1 |
6357875 | Herrick | Mar 2002 | B1 |
6358280 | Herrick | Mar 2002 | B1 |
6364483 | Grossinger et al. | Apr 2002 | B1 |
6365074 | Su | Apr 2002 | B1 |
6390623 | Kokonaski et al. | May 2002 | B1 |
6474814 | Griffin | Nov 2002 | B1 |
6505934 | Menezes | Jan 2003 | B1 |
6536899 | Fiala | Mar 2003 | B1 |
6630083 | Nunez et al. | Oct 2003 | B1 |
6638304 | Azar | Oct 2003 | B2 |
6685315 | De Carle | Feb 2004 | B1 |
6709105 | Menezes | Mar 2004 | B2 |
6855164 | Glazier | Feb 2005 | B2 |
6883916 | Menezes | Apr 2005 | B2 |
6932839 | Kamerling et al. | Aug 2005 | B1 |
6951391 | Morris et al. | Oct 2005 | B2 |
7025456 | Morris et al. | Apr 2006 | B2 |
7041133 | Azar | May 2006 | B1 |
7073906 | Portney | Jul 2006 | B1 |
7093938 | Morris et al. | Aug 2006 | B2 |
7141065 | Azar | Nov 2006 | B2 |
7144423 | McDonald | Dec 2006 | B2 |
7152975 | Ho et al. | Dec 2006 | B2 |
7156516 | Morris et al. | Jan 2007 | B2 |
7159983 | Menezes et al. | Jan 2007 | B2 |
7178918 | Griffin | Feb 2007 | B2 |
7229173 | Menezes | Jun 2007 | B2 |
7229475 | Glazier | Jun 2007 | B2 |
7232218 | Morris et al. | Jun 2007 | B2 |
7256921 | Kumar et al. | Aug 2007 | B2 |
7261736 | Azar | Aug 2007 | B1 |
7270677 | Azar | Sep 2007 | B2 |
7281795 | Sandstedt et al. | Oct 2007 | B2 |
7286275 | Kumar et al. | Oct 2007 | B2 |
7331668 | Azar et al. | Feb 2008 | B2 |
7334892 | Goodall et al. | Feb 2008 | B2 |
7334894 | Hillis et al. | Feb 2008 | B2 |
RE40152 | Maus et al. | Mar 2008 | E |
7338161 | Chauveau et al. | Mar 2008 | B2 |
7341345 | Azar et al. | Mar 2008 | B2 |
7342112 | Kumar et al. | Mar 2008 | B2 |
7344244 | Goodall et al. | Mar 2008 | B2 |
7349137 | Kumar et al. | Mar 2008 | B2 |
7349138 | Kumar et al. | Mar 2008 | B2 |
7350919 | Hillis et al. | Apr 2008 | B2 |
7359104 | Kumar et al. | Apr 2008 | B2 |
7364294 | Menezes | Apr 2008 | B2 |
7377641 | Piers et al. | May 2008 | B2 |
7390088 | Goodall et al. | Jun 2008 | B2 |
7394585 | Kumar et al. | Jul 2008 | B2 |
7429105 | Kumar et al. | Sep 2008 | B2 |
7318642 | Menezes | Oct 2008 | B2 |
7441894 | Zhang et al. | Oct 2008 | B2 |
7452075 | Iuliano | Nov 2008 | B2 |
7457025 | Kumar et al. | Nov 2008 | B2 |
7457434 | Azar | Nov 2008 | B2 |
7465415 | Wang et al. | Dec 2008 | B2 |
7466469 | Kumar et al. | Dec 2008 | B2 |
7470027 | Hillis et al. | Dec 2008 | B2 |
7471436 | Kumar et al. | Dec 2008 | B2 |
7481532 | Hong et al. | Jan 2009 | B2 |
7481955 | Xiao | Jan 2009 | B2 |
7486988 | Goodall et al. | Feb 2009 | B2 |
7505189 | Kumar et al. | Mar 2009 | B2 |
7527754 | Chopra | May 2009 | B2 |
7543937 | Piers et al. | Jun 2009 | B2 |
7553925 | Bojkova | Jun 2009 | B2 |
7556381 | Kelch et al. | Jul 2009 | B2 |
7557206 | Kumar et al. | Jul 2009 | B2 |
7560124 | Kumar et al. | Jul 2009 | B2 |
7579022 | Kumar et al. | Aug 2009 | B2 |
7582749 | Kumar et al. | Sep 2009 | B2 |
7594727 | Hillis et al. | Sep 2009 | B2 |
7623295 | Sabeta | Nov 2009 | B2 |
7632540 | Kumar et al. | Dec 2009 | B2 |
7641337 | Altmann | Jan 2010 | B2 |
7655002 | Myers | Feb 2010 | B2 |
7656569 | Hillis et al. | Feb 2010 | B2 |
7666510 | Stewart | Feb 2010 | B2 |
7687597 | Bojkova | Mar 2010 | B2 |
7696296 | Bojkova et al. | Apr 2010 | B2 |
7699464 | Iuliano | Apr 2010 | B2 |
7717558 | Hong et al. | May 2010 | B2 |
7728949 | Clarke et al. | Jun 2010 | B2 |
7812295 | Zalevsky et al. | Oct 2010 | B2 |
7819523 | Shimojo | Oct 2010 | B2 |
7828430 | Ballet et al. | Nov 2010 | B2 |
7828431 | Ho et al. | Nov 2010 | B2 |
7832857 | Levinson et al. | Nov 2010 | B2 |
7833442 | Chen et al. | Nov 2010 | B2 |
7847998 | Kumar et al. | Dec 2010 | B2 |
7850879 | Cheb et al. | Dec 2010 | B2 |
7883206 | Blum et al. | Feb 2011 | B2 |
7888436 | Szymanski et al. | Feb 2011 | B2 |
7891809 | Ballet et al. | Feb 2011 | B2 |
7901076 | Azar et al. | Mar 2011 | B2 |
7906214 | Seybert et al. | Mar 2011 | B2 |
7910019 | He et al. | Mar 2011 | B2 |
7910020 | He et al. | Mar 2011 | B2 |
7926940 | Blum et al. | Apr 2011 | B2 |
7931373 | Hillis et al. | Apr 2011 | B2 |
7978391 | Kumar et al. | Jul 2011 | B2 |
7988285 | Sandstedt et al. | Aug 2011 | B2 |
8003005 | He et al. | Aug 2011 | B2 |
8038711 | Clarke | Oct 2011 | B2 |
8077373 | Kumar et al. | Dec 2011 | B2 |
8084133 | Colton | Dec 2011 | B2 |
8089678 | Kumar et al. | Jan 2012 | B2 |
8100527 | Hong et al. | Jan 2012 | B2 |
8104892 | Hillis et al. | Jan 2012 | B2 |
8109632 | Hillis et al. | Feb 2012 | B2 |
8153344 | Faler et al. | Apr 2012 | B2 |
8211338 | He et al. | Jul 2012 | B2 |
8215770 | Blum et al. | Jul 2012 | B2 |
8216308 | Blake et al. | Jul 2012 | B2 |
8216309 | Azar | Jul 2012 | B2 |
8220477 | Park | Jul 2012 | B2 |
8231217 | Ballet et al. | Jul 2012 | B2 |
8235525 | Lesage et al. | Aug 2012 | B2 |
8240850 | Apter et al. | Aug 2012 | B2 |
8244342 | Goodall et al. | Aug 2012 | B2 |
8262727 | McDonald | Sep 2012 | B2 |
8262728 | Zhang et al. | Sep 2012 | B2 |
8267515 | Azar et al. | Sep 2012 | B2 |
8282212 | Hillis et al. | Oct 2012 | B2 |
8308295 | Blum et al. | Nov 2012 | B2 |
8319937 | Clarke et al. | Nov 2012 | B2 |
8349210 | Xu et al. | Jan 2013 | B2 |
8431039 | Dia et al. | Apr 2013 | B2 |
8434865 | Blum et al. | May 2013 | B2 |
8475529 | Clake | Jul 2013 | B2 |
8507050 | Faler et al. | Aug 2013 | B2 |
8518546 | He et al. | Aug 2013 | B2 |
8535577 | Chopra et al. | Sep 2013 | B2 |
8545015 | Kumar et al. | Oct 2013 | B2 |
8545984 | He et al. | Oct 2013 | B2 |
8556416 | Lawu | Oct 2013 | B2 |
8562540 | Goodall et al. | Oct 2013 | B2 |
8563212 | Bowles et al. | Oct 2013 | B2 |
8563213 | Bowles et al. | Oct 2013 | B2 |
8582192 | Kumar et al. | Nov 2013 | B2 |
8587734 | Li | Nov 2013 | B2 |
8608800 | Portney | Dec 2013 | B2 |
8613868 | Dai et al. | Dec 2013 | B2 |
8619362 | Portney | Dec 2013 | B2 |
8623238 | Xu et al. | Jan 2014 | B2 |
8628685 | He et al. | Jan 2014 | B2 |
8647538 | Lu et al. | Feb 2014 | B2 |
8649081 | DeMeio et al. | Feb 2014 | B1 |
8678583 | Cohen | Mar 2014 | B2 |
8698117 | He et al. | Apr 2014 | B2 |
8705160 | He et al. | Apr 2014 | B2 |
8747466 | Weeber et al. | Jun 2014 | B2 |
8779168 | He et al. | Jul 2014 | B2 |
8789951 | Thompson et al. | Jul 2014 | B2 |
8807746 | Kato et al. | Aug 2014 | B2 |
8828284 | Carpenter | Sep 2014 | B2 |
8828296 | Zhang et al. | Sep 2014 | B2 |
8828507 | He et al. | Sep 2014 | B2 |
8848288 | Retsch, Jr. | Sep 2014 | B2 |
8859097 | Chopra | Oct 2014 | B2 |
8871016 | Trexler et al. | Oct 2014 | B2 |
8882264 | Bradley et al. | Nov 2014 | B2 |
8885139 | Peyghambarian et al. | Nov 2014 | B2 |
8888277 | Jubin et al. | Nov 2014 | B2 |
8889807 | Hickenboth et al. | Nov 2014 | B2 |
8894203 | Bradley et al. | Nov 2014 | B2 |
8894204 | Weeber et al. | Nov 2014 | B2 |
8894706 | Portney | Nov 2014 | B2 |
8920928 | He et al. | Dec 2014 | B2 |
8926091 | Kumar et al. | Jan 2015 | B2 |
8992610 | Blum et al. | Mar 2015 | B2 |
9001316 | Mohan et al. | Apr 2015 | B2 |
9028728 | Bancroft et al. | May 2015 | B2 |
9029532 | Dabideen et al. | May 2015 | B2 |
9029565 | He et al. | May 2015 | B1 |
9030740 | DeMeio et al. | May 2015 | B2 |
9034219 | He et al. | May 2015 | B2 |
9040648 | Hickenboth et al. | May 2015 | B2 |
9045647 | Kleyer et al. | Jun 2015 | B2 |
9051332 | He et al. | Jun 2015 | B1 |
9051426 | Hickenboth et al. | Jun 2015 | B2 |
9062213 | Bradford et al. | Jun 2015 | B2 |
9081208 | Blum et al. | Jul 2015 | B2 |
9091864 | Kingston et al. | Jul 2015 | B2 |
9096014 | Kumar et al. | Aug 2015 | B2 |
9096026 | Hall et al. | Aug 2015 | B2 |
9101466 | Hong | Aug 2015 | B2 |
9116363 | Pugh et al. | Aug 2015 | B2 |
9122083 | Blum et al. | Sep 2015 | B2 |
9139552 | Xiao et al. | Sep 2015 | B2 |
9146407 | Clarke et al. | Sep 2015 | B2 |
9155483 | Hillis et al. | Oct 2015 | B2 |
9173717 | Tripathi | Nov 2015 | B2 |
9175153 | Trexler et al. | Nov 2015 | B2 |
9206151 | He et al. | Dec 2015 | B2 |
9216080 | Bogaert et al. | Dec 2015 | B2 |
9223148 | Fiala et al. | Dec 2015 | B2 |
9226798 | Tripathi et al. | Jan 2016 | B2 |
9259309 | Fehr et al. | Feb 2016 | B2 |
9259310 | Schachar et al. | Feb 2016 | B2 |
9277988 | Chu | Mar 2016 | B1 |
9279907 | Bojkova | Mar 2016 | B2 |
9304329 | Zhao | Apr 2016 | B2 |
9309455 | He et al. | Apr 2016 | B2 |
9320594 | Schwiegerling | Apr 2016 | B2 |
9323073 | Pugh et al. | Apr 2016 | B2 |
9332899 | Shea et al. | May 2016 | B2 |
9334345 | Herold et al. | May 2016 | B2 |
9334439 | DeMeio et al. | May 2016 | B2 |
9335564 | Choi et al. | May 2016 | B2 |
9405041 | He et al. | Aug 2016 | B2 |
9411076 | Slezak et al. | Aug 2016 | B2 |
9427313 | Currie | Aug 2016 | B2 |
9433496 | Clough | Sep 2016 | B2 |
9441080 | Trexler et al. | Sep 2016 | B2 |
9454021 | Guillon et al. | Sep 2016 | B2 |
9459470 | Hillis et al. | Oct 2016 | B2 |
9469731 | Bojkova | Oct 2016 | B2 |
9474594 | Schachar et al. | Oct 2016 | B2 |
9475901 | Saha et al. | Oct 2016 | B2 |
9523004 | Hervieu et al. | Dec 2016 | B2 |
9526656 | Serdarevic et al. | Dec 2016 | B2 |
9532904 | Serdarevic et al. | Jan 2017 | B2 |
9545339 | Serdarevic et al. | Jan 2017 | B2 |
9563070 | Ando et al. | Feb 2017 | B2 |
9568643 | Bojkova et al. | Feb 2017 | B2 |
9568744 | Pugh et al. | Feb 2017 | B2 |
9588396 | Haddock et al. | Mar 2017 | B2 |
9594259 | Brennan et al. | Mar 2017 | B2 |
9630902 | He et al. | Apr 2017 | B2 |
9658471 | Ando et al. | May 2017 | B2 |
9664923 | Wildsmith et al. | May 2017 | B2 |
9675444 | Blum et al. | Jun 2017 | B2 |
9690021 | Turpen et al. | Jun 2017 | B2 |
9693679 | Dorronsoro Diaz et al. | Jul 2017 | B2 |
9724190 | Weeber et al. | Aug 2017 | B2 |
9733488 | Ambler et al. | Aug 2017 | B2 |
9733489 | Paille et al. | Aug 2017 | B2 |
9770326 | Bradley et al. | Sep 2017 | B2 |
9782064 | Linder et al. | Oct 2017 | B1 |
9891349 | Bojkova et al. | Feb 2018 | B2 |
9895260 | Schachar et al. | Feb 2018 | B2 |
9927633 | Franklin et al. | Mar 2018 | B2 |
9955862 | Freeman et al. | May 2018 | B2 |
9963546 | Bhagwager et al. | May 2018 | B2 |
9987127 | Bogaert et al. | Jun 2018 | B2 |
10000472 | He et al. | Jun 2018 | B2 |
10005763 | He et al. | Jun 2018 | B2 |
10007038 | Kumar et al. | Jun 2018 | B2 |
10010406 | Sandstedt et al. | Jul 2018 | B2 |
10012773 | Bojkova et al. | Jul 2018 | B2 |
10012848 | Brennan et al. | Jul 2018 | B2 |
10039635 | Wanders | Aug 2018 | B2 |
10052195 | Blum et al. | Aug 2018 | B2 |
10061143 | Brennan et al. | Aug 2018 | B2 |
10085833 | Piers et al. | Oct 2018 | B2 |
10111583 | Freeman et al. | Oct 2018 | B1 |
10114235 | Blum et al. | Oct 2018 | B2 |
10145996 | DeMeio et al. | Dec 2018 | B2 |
10155858 | Bhagwagar et al. | Dec 2018 | B2 |
10175508 | Ambier et al. | Jan 2019 | B2 |
10185057 | Colton et al. | Jan 2019 | B2 |
10209533 | Schwiegerling | Feb 2019 | B2 |
10213358 | Dorronsoro Diaz et al. | Feb 2019 | B2 |
10219893 | Currie et al. | Mar 2019 | B2 |
10226327 | Fernandez Gutierrez et al. | Mar 2019 | B2 |
10278809 | Gerlach | May 2019 | B2 |
10278810 | Clamen et al. | May 2019 | B2 |
10278811 | Choi et al. | May 2019 | B2 |
10281628 | Koenig, II et al. | May 2019 | B2 |
10285806 | Choi et al. | May 2019 | B2 |
10295841 | Ando | May 2019 | B2 |
10302968 | Waite et al. | May 2019 | B2 |
10308618 | Fromentin et al. | Jun 2019 | B2 |
10342700 | Schachar et al. | Jul 2019 | B2 |
10371866 | Frease et al. | Aug 2019 | B2 |
10398544 | Sayegh | Sep 2019 | B2 |
10409088 | Hillis et al. | Sep 2019 | B2 |
10420638 | Hong et al. | Sep 2019 | B2 |
10423061 | Tomasulo et al. | Sep 2019 | B2 |
10426599 | Choi et al. | Oct 2019 | B2 |
10444537 | Kumar et al. | Oct 2019 | B2 |
10444543 | Thompson | Oct 2019 | B2 |
10463474 | Lux et al. | Nov 2019 | B2 |
10466487 | Blum et al. | Nov 2019 | B2 |
10473822 | Fan et al. | Nov 2019 | B2 |
10493486 | Lynch et al. | Dec 2019 | B2 |
10501446 | He et al. | Dec 2019 | B2 |
10501477 | Deng et al. | Dec 2019 | B2 |
10517716 | Luque | Dec 2019 | B2 |
10524899 | Lux et al. | Jan 2020 | B2 |
10532997 | He et al. | Jan 2020 | B2 |
10532998 | He et al. | Jan 2020 | B2 |
10543577 | Masad et al. | Jan 2020 | B2 |
10564448 | Ando | Feb 2020 | B2 |
10568734 | Mackool | Feb 2020 | B2 |
10571611 | Koenig, II et al. | Feb 2020 | B2 |
10590220 | Saha et al. | Mar 2020 | B2 |
10598960 | Blum et al. | Mar 2020 | B2 |
10619018 | Kumar et al. | Apr 2020 | B2 |
10619098 | Reddy et al. | Apr 2020 | B2 |
10646329 | Zhao | May 2020 | B2 |
10649234 | Zhao | May 2020 | B2 |
10670885 | Zhao | Jun 2020 | B2 |
10675146 | Choi et al. | Jun 2020 | B2 |
10688522 | Lynch et al. | Jun 2020 | B2 |
10698234 | Zhao | Jun 2020 | B2 |
10709546 | Peyman | Jul 2020 | B2 |
10712589 | Zhao | Jul 2020 | B2 |
10725320 | Schwiegerling | Jul 2020 | B2 |
10747021 | Franklin et al. | Aug 2020 | B2 |
10747022 | Ando et al. | Aug 2020 | B2 |
10765510 | Sarver et al. | Sep 2020 | B2 |
10786959 | Damodharan et al. | Sep 2020 | B2 |
10835374 | Barzilay | Nov 2020 | B2 |
10838111 | Fromentin | Nov 2020 | B2 |
10842617 | Hong et al. | Nov 2020 | B2 |
10849736 | Neuhann et al. | Dec 2020 | B2 |
10874297 | Freeman et al. | Dec 2020 | B1 |
10874505 | Sandstedt et al. | Dec 2020 | B2 |
10875833 | Kumar et al. | Dec 2020 | B2 |
10884246 | Blum et al. | Jan 2021 | B2 |
10884288 | He et al. | Jan 2021 | B2 |
10905543 | Ghabra et al. | Feb 2021 | B2 |
10912457 | Schmeder | Feb 2021 | B2 |
10932901 | Zheleznyak et al. | Mar 2021 | B2 |
10993798 | Choi et al. | May 2021 | B2 |
10994563 | Frease et al. | May 2021 | B2 |
11000361 | Hong et al. | May 2021 | B2 |
11000365 | Choi et al. | May 2021 | B2 |
11000366 | Choi et al. | May 2021 | B2 |
11009723 | Ando | May 2021 | B2 |
11029536 | Lux et al. | Jun 2021 | B2 |
11039901 | Tripathi | Jun 2021 | B2 |
11051884 | Tripathi et al. | Jul 2021 | B2 |
11076987 | Schachar et al. | Aug 2021 | B2 |
11084236 | Turpen et al. | Aug 2021 | B2 |
11103344 | Zhang | Aug 2021 | B2 |
11123178 | Zhao | Sep 2021 | B2 |
11129707 | Pagnoulle et al. | Sep 2021 | B2 |
11130912 | Kumar et al. | Sep 2021 | B2 |
11135052 | Goldshleger et al. | Oct 2021 | B2 |
11143887 | Waite et al. | Oct 2021 | B2 |
20010027315 | Largent | Oct 2001 | A1 |
20020093701 | Zhang et al. | Jul 2002 | A1 |
20020101564 | Herrick | Aug 2002 | A1 |
20020196410 | Menezes | Dec 2002 | A1 |
20030018383 | Azar | Jan 2003 | A1 |
20030081171 | Griffin | May 2003 | A1 |
20030093149 | Glazier | May 2003 | A1 |
20030099330 | Mery et al. | May 2003 | A1 |
20030151831 | Sandstedt et al. | Aug 2003 | A1 |
20030187505 | Liao | Oct 2003 | A1 |
20040075807 | Ho et al. | Apr 2004 | A1 |
20040080711 | Menezes | Apr 2004 | A1 |
20040082995 | Woods | Apr 2004 | A1 |
20040199149 | Myers et al. | Oct 2004 | A1 |
20040252274 | Morris et al. | Dec 2004 | A1 |
20050003107 | Kumar et al. | Jan 2005 | A1 |
20050004361 | Kumar et al. | Jan 2005 | A1 |
20050012998 | Kumar et al. | Jan 2005 | A1 |
20050021138 | Woods | Jan 2005 | A1 |
20050021140 | Liao | Jan 2005 | A1 |
20050057720 | Morris et al. | Mar 2005 | A1 |
20050068493 | Menezes | Mar 2005 | A1 |
20050068494 | Griffin | Mar 2005 | A1 |
20050071002 | Glazier | Mar 2005 | A1 |
20050099597 | Sandstedt et al. | May 2005 | A1 |
20050140922 | Bekerman et al. | May 2005 | A1 |
20050168689 | Knox | Aug 2005 | A1 |
20050182490 | McDonald | Aug 2005 | A1 |
20050187622 | Sandstedt et al. | Aug 2005 | A1 |
20050259222 | Kelch et al. | Nov 2005 | A1 |
20050264757 | Morris et al. | Dec 2005 | A1 |
20060014099 | Faler et al. | Jan 2006 | A1 |
20060022176 | Wang et al. | Feb 2006 | A1 |
20060023162 | Azar et al. | Feb 2006 | A1 |
20060050234 | Morris et al. | Mar 2006 | A1 |
20060050236 | Menezes | Mar 2006 | A1 |
20060055883 | Morris et al. | Mar 2006 | A1 |
20060066808 | Blum et al. | Mar 2006 | A1 |
20060089713 | Azar | Apr 2006 | A1 |
20060092375 | Menezes et al. | May 2006 | A1 |
20060100704 | Blake et al. | May 2006 | A1 |
20060116764 | Simpson | Jun 2006 | A1 |
20060116765 | Blake et al. | Jun 2006 | A1 |
20060119793 | Hillis et al. | Jun 2006 | A1 |
20060119794 | Hillis et al. | Jun 2006 | A1 |
20060122530 | Goodall et al. | Jun 2006 | A1 |
20060122531 | Goodall et al. | Jun 2006 | A1 |
20060146281 | Goodall et al. | Jul 2006 | A1 |
20060164593 | Peyghambarian et al. | Jul 2006 | A1 |
20060176449 | Azar et al. | Aug 2006 | A1 |
20060203189 | Ho et al. | Sep 2006 | A1 |
20060206204 | Azar | Sep 2006 | A1 |
20060206205 | Azar | Sep 2006 | A1 |
20060224238 | Azar | Oct 2006 | A1 |
20060244906 | Piers et al. | Nov 2006 | A1 |
20060293747 | McDonald | Dec 2006 | A1 |
20070010757 | Goodall et al. | Jan 2007 | A1 |
20070019157 | Hillis et al. | Jan 2007 | A1 |
20070019272 | Hillis et al. | Jan 2007 | A1 |
20070019279 | Goodall et al. | Jan 2007 | A1 |
20070021831 | Clarke | Jan 2007 | A1 |
20070028931 | Hillis et al. | Feb 2007 | A1 |
20070030444 | Chauveau et al. | Feb 2007 | A1 |
20070030445 | Menezes | Feb 2007 | A1 |
20070041071 | Kumar et al. | Feb 2007 | A1 |
20070041073 | Kumar et al. | Feb 2007 | A1 |
20070047053 | Kumar et al. | Mar 2007 | A1 |
20070047054 | Kumar et al. | Mar 2007 | A1 |
20070047055 | Kumar et al. | Mar 2007 | A1 |
20070053047 | Kumar et al. | Mar 2007 | A1 |
20070053048 | Kumar et al. | Mar 2007 | A1 |
20070053049 | Kumar et al. | Mar 2007 | A1 |
20070053050 | Kumar et al. | Mar 2007 | A1 |
20070054131 | Stewart | Mar 2007 | A1 |
20070067030 | Glazier et al. | Mar 2007 | A1 |
20070075388 | Kumar et al. | Apr 2007 | A1 |
20070076167 | Kumar et al. | Apr 2007 | A1 |
20070098968 | Kumar et al. | May 2007 | A1 |
20070138448 | Chopra | Jun 2007 | A1 |
20070138665 | Chen et al. | Jun 2007 | A1 |
20070145337 | Chopra | Jun 2007 | A1 |
20070153231 | Iuliano | Jul 2007 | A1 |
20070177100 | Knox | Aug 2007 | A1 |
20070182917 | Zhang et al. | Aug 2007 | A1 |
20070182921 | Zhang et al. | Aug 2007 | A1 |
20070182924 | Hong | Aug 2007 | A1 |
20070216863 | Menzes | Sep 2007 | A1 |
20070258143 | Portney | Nov 2007 | A1 |
20070260307 | Azar | Nov 2007 | A1 |
20070270548 | Bojkova et al. | Nov 2007 | A1 |
20070270549 | Szymanski et al. | Nov 2007 | A1 |
20070274626 | Sabeta | Nov 2007 | A1 |
20070275098 | Banks | Nov 2007 | A1 |
20070278460 | Xiao | Dec 2007 | A1 |
20070278461 | Petrovskaia et al. | Dec 2007 | A1 |
20070286969 | Nagpal et al. | Dec 2007 | A1 |
20070291345 | Kumar et al. | Dec 2007 | A1 |
20080045704 | Kumar et al. | Feb 2008 | A1 |
20080051575 | Kumar et al. | Feb 2008 | A1 |
20080086207 | Sandstedt et al. | Apr 2008 | A1 |
20080095933 | Colton et al. | Apr 2008 | A1 |
20080096023 | Colton et al. | Apr 2008 | A1 |
20080096048 | Kumar et al. | Apr 2008 | A1 |
20080096049 | Kumar et al. | Apr 2008 | A1 |
20080123172 | Kumar et al. | May 2008 | A1 |
20080125525 | Bojkova | May 2008 | A1 |
20080125570 | Bojkova | May 2008 | A1 |
20080137031 | Hillis et al. | Jun 2008 | A1 |
20080151183 | Altmann | Jun 2008 | A1 |
20080160318 | Senkfor et al. | Jul 2008 | A1 |
20080161673 | Goodall et al. | Jul 2008 | A1 |
20080180630 | Clarke et al. | Jul 2008 | A1 |
20080180803 | Seybert et al. | Jul 2008 | A1 |
20080187749 | Cael et al. | Aug 2008 | A1 |
20080198326 | Piers et al. | Aug 2008 | A1 |
20080198331 | Azar et al. | Aug 2008 | A1 |
20080206579 | LaLumere et al. | Aug 2008 | A1 |
20080212017 | Ballet et al. | Sep 2008 | A1 |
20080212023 | Bovet et al. | Sep 2008 | A1 |
20080218689 | Blum et al. | Sep 2008 | A1 |
20080231799 | Iuliano | Dec 2008 | A1 |
20080297720 | Ballet et al. | Dec 2008 | A1 |
20090033863 | Blum et al. | Feb 2009 | A1 |
20090082859 | Azar | Mar 2009 | A1 |
20090088840 | Simpson | Apr 2009 | A1 |
20090096981 | Clarke et al. | Apr 2009 | A1 |
20090122262 | Hong et al. | May 2009 | A1 |
20090124721 | Chen et al. | May 2009 | A1 |
20090125105 | Lesage et al. | May 2009 | A1 |
20090135462 | Kumar et al. | May 2009 | A1 |
20090146104 | He et al. | Jun 2009 | A1 |
20090147378 | Zelevsky et al. | Jun 2009 | A1 |
20090187242 | Weeber et al. | Jul 2009 | A1 |
20090189830 | Deering et al. | Jul 2009 | A1 |
20090195751 | Hillis et al. | Aug 2009 | A1 |
20090204207 | Blum et al. | Aug 2009 | A1 |
20090239043 | Kondos et al. | Sep 2009 | A1 |
20090240328 | Treushnikov et al. | Sep 2009 | A1 |
20090268155 | Weeber | Oct 2009 | A1 |
20090303433 | Shimojo | Dec 2009 | A1 |
20090309076 | He et al. | Dec 2009 | A1 |
20090323011 | He et al. | Dec 2009 | A1 |
20090323012 | He et al. | Dec 2009 | A1 |
20100016962 | Hong et al. | Jan 2010 | A1 |
20100035067 | Colton | Feb 2010 | A1 |
20100039612 | Levinson et al. | Feb 2010 | A1 |
20100065625 | Sabeta | Mar 2010 | A1 |
20100066973 | Portney | Mar 2010 | A1 |
20100076554 | Sandstedt et al. | Mar 2010 | A1 |
20100094262 | Tripathi et al. | Apr 2010 | A1 |
20100103373 | Hillis et al. | Apr 2010 | A1 |
20100114079 | Myers et al. | May 2010 | A1 |
20100118260 | Ballet et al. | May 2010 | A1 |
20100119735 | Faler et al. | May 2010 | A1 |
20100134754 | Hong | Jun 2010 | A1 |
20100157241 | Kumar et al. | Jun 2010 | A1 |
20100161051 | Hong | Jun 2010 | A1 |
20100177279 | Hillis et al. | Jul 2010 | A1 |
20100188636 | Pinto et al. | Jul 2010 | A1 |
20100209697 | Bowles et al. | Aug 2010 | A1 |
20100217278 | Tripathi | Aug 2010 | A1 |
20100221661 | Bowles et al. | Sep 2010 | A1 |
20100225834 | Li | Sep 2010 | A1 |
20100259719 | Sabeta | Oct 2010 | A1 |
20100281021 | Weeber et al. | Nov 2010 | A1 |
20100286771 | Zhang et al. | Nov 2010 | A1 |
20100321635 | Apter et al. | Dec 2010 | A1 |
20110023924 | Park | Feb 2011 | A1 |
20110080628 | Kumar et al. | Apr 2011 | A1 |
20110112634 | Azar et al. | May 2011 | A1 |
20110128457 | He et al. | Jun 2011 | A1 |
20110129678 | He et al. | Jun 2011 | A1 |
20110135850 | Saha et al. | Jun 2011 | A1 |
20110140056 | He et al. | Jun 2011 | A1 |
20110143141 | He et al. | Jun 2011 | A1 |
20110157548 | Lesage et al. | Jun 2011 | A1 |
20110166652 | Bogaert et al. | Jul 2011 | A1 |
20110194069 | Blum et al. | Aug 2011 | A1 |
20110216273 | He et al. | Sep 2011 | A1 |
20110234974 | Lawu | Sep 2011 | A1 |
20110270389 | Glazer et al. | Nov 2011 | A1 |
20110279883 | Kumar et al. | Nov 2011 | A1 |
20110285959 | Gupta et al. | Nov 2011 | A1 |
20110292335 | Schwiegerling | Dec 2011 | A1 |
20120002141 | Dai et al. | Jan 2012 | A1 |
20120003401 | Xu et al. | Jan 2012 | A1 |
20120016350 | Myers et al. | Jan 2012 | A1 |
20120021144 | Dai et al. | Jan 2012 | A1 |
20120027960 | Xu et al. | Feb 2012 | A1 |
20120035724 | Clarke | Feb 2012 | A1 |
20120061863 | Cox et al. | Mar 2012 | A1 |
20120086910 | Kato et al. | Apr 2012 | A1 |
20120092613 | Azar | Apr 2012 | A1 |
20120120473 | Kumar et al. | May 2012 | A1 |
20120126185 | He et al. | May 2012 | A1 |
20120132870 | Xiao et al. | May 2012 | A1 |
20120136148 | Lu et al. | May 2012 | A1 |
20120140166 | Zhao | Jun 2012 | A1 |
20120140167 | Blum | Jun 2012 | A1 |
20120145973 | Bancroft et al. | Jun 2012 | A1 |
20120154740 | Bradley et al. | Jun 2012 | A1 |
20120156508 | He et al. | Jun 2012 | A1 |
20120156521 | He et al. | Jun 2012 | A1 |
20120157677 | He et al. | Jun 2012 | A1 |
20120176581 | Bradley et al. | Jul 2012 | A1 |
20120179248 | Azar | Jul 2012 | A1 |
20120183810 | Chopra | Jul 2012 | A1 |
20120200907 | He et al. | Aug 2012 | A1 |
20120206691 | Ivai | Aug 2012 | A1 |
20120212696 | Trajkovska et al. | Aug 2012 | A1 |
20120214992 | Chopra et al. | Aug 2012 | A1 |
20120224138 | Cohen | Sep 2012 | A1 |
20120224139 | Retsch, Jr. | Sep 2012 | A1 |
20120236257 | Hillis et al. | Sep 2012 | A1 |
20120267030 | Hall et al. | Oct 2012 | A1 |
20120286435 | Bojkova et al. | Nov 2012 | A1 |
20120320335 | Weeber et al. | Dec 2012 | A1 |
20120323320 | Simonov et al. | Dec 2012 | A1 |
20120330414 | McDonald | Dec 2012 | A1 |
20130004780 | Hervieu et al. | Jan 2013 | A1 |
20130027655 | Blum et al. | Jan 2013 | A1 |
20130032059 | Trexler et al. | Feb 2013 | A1 |
20130035760 | Portney | Feb 2013 | A1 |
20130050640 | Fiala et al. | Feb 2013 | A1 |
20130050651 | Azar et al. | Feb 2013 | A1 |
20130069274 | Zhang et al. | Mar 2013 | A1 |
20130070199 | Blum et al. | Mar 2013 | A1 |
20130072591 | Sandstedt et al. | Mar 2013 | A1 |
20130073038 | Azar | Mar 2013 | A1 |
20130082220 | Herold et al. | Apr 2013 | A1 |
20130122221 | Colton et al. | May 2013 | A1 |
20130176536 | Thompson et al. | Jul 2013 | A1 |
20130208347 | Haddock et al. | Aug 2013 | A1 |
20130211515 | Blum et al. | Aug 2013 | A1 |
20130211516 | Blum et al. | Aug 2013 | A1 |
20130215374 | Blum et al. | Aug 2013 | A1 |
20130218269 | Schachar et al. | Aug 2013 | A1 |
20130225777 | Hickenboth et al. | Aug 2013 | A1 |
20130228100 | Kleyer et al. | Sep 2013 | A1 |
20130231741 | Clarke | Sep 2013 | A1 |
20130245754 | Blum et al. | Sep 2013 | A1 |
20130261744 | Gupta et al. | Oct 2013 | A1 |
20130273380 | Hickenboth et al. | Oct 2013 | A1 |
20130274412 | Hickenboth et al. | Oct 2013 | A1 |
20130278891 | Zhao | Oct 2013 | A1 |
20130289153 | Sandstedt et al. | Oct 2013 | A1 |
20130308094 | Mohan et al. | Nov 2013 | A1 |
20130308186 | Cathey, Jr. | Nov 2013 | A1 |
20130335701 | Canovas Vidal et al. | Dec 2013 | A1 |
20130338767 | Mazzocchi et al. | Dec 2013 | A1 |
20140043672 | Clarke et al. | Feb 2014 | A1 |
20140055744 | Wildsmith et al. | Feb 2014 | A1 |
20140066537 | Jerome et al. | Mar 2014 | A1 |
20140078583 | DeMeio et al. | Mar 2014 | A1 |
20140080972 | Slezak et al. | Mar 2014 | A1 |
20140107777 | Portney | Apr 2014 | A1 |
20140118683 | Jubin et al. | May 2014 | A1 |
20140125949 | Shea et al. | May 2014 | A1 |
20140125954 | Kingston et al. | May 2014 | A1 |
20140148899 | Fehr et al. | May 2014 | A1 |
20140152953 | Guillon et al. | Jun 2014 | A1 |
20140154514 | He et al. | Jun 2014 | A1 |
20140155572 | Bojkova | Jun 2014 | A1 |
20140166948 | He et al. | Jun 2014 | A1 |
20140171612 | Bojkova et al. | Jun 2014 | A1 |
20140178513 | Matthews | Jun 2014 | A1 |
20140199521 | Carpenter | Jul 2014 | A1 |
20140232982 | Iwai | Aug 2014 | A1 |
20140240657 | Pugh et al. | Aug 2014 | A1 |
20140243972 | Wanders | Aug 2014 | A1 |
20140256935 | Dabideen et al. | Sep 2014 | A1 |
20140264979 | Park et al. | Sep 2014 | A1 |
20140265010 | Park et al. | Sep 2014 | A1 |
20140272111 | Bradford et al. | Sep 2014 | A1 |
20140272468 | DeMeio et al. | Sep 2014 | A1 |
20140277051 | Schachar et al. | Sep 2014 | A1 |
20140277437 | Currie | Sep 2014 | A1 |
20140327875 | Blum et al. | Nov 2014 | A1 |
20140340632 | Pugh et al. | Nov 2014 | A1 |
20140347624 | Ando et al. | Nov 2014 | A1 |
20140350672 | Hong | Nov 2014 | A1 |
20150005877 | Wanders | Jan 2015 | A1 |
20150022775 | Ando et al. | Jan 2015 | A1 |
20150029460 | Bradley et al. | Jan 2015 | A1 |
20150044446 | Trexler et al. | Feb 2015 | A1 |
20150057748 | Azar | Feb 2015 | A1 |
20150088253 | Doll et al. | Mar 2015 | A1 |
20150131056 | Paille et al. | May 2015 | A1 |
20150133901 | Serdarevic et al. | May 2015 | A1 |
20150138492 | Kumar et al. | May 2015 | A1 |
20150141661 | He et al. | May 2015 | A1 |
20150141662 | He et al. | May 2015 | A1 |
20150141663 | He et al. | May 2015 | A1 |
20150152271 | Bradford et al. | Jun 2015 | A1 |
20150159022 | Bradford et al. | Jun 2015 | A1 |
20150182331 | Blum et al. | Jul 2015 | A1 |
20150230979 | Serdarevic et al. | Aug 2015 | A1 |
20150230985 | Serdarevic et al. | Aug 2015 | A1 |
20150274910 | Kumar et al. | Oct 2015 | A1 |
20150331253 | Choi et al. | Nov 2015 | A1 |
20150342727 | Fernandez Gutierrez et al. | Dec 2015 | A1 |
20150362748 | Pugh et al. | Dec 2015 | A1 |
20150368408 | Trexler et al. | Dec 2015 | A1 |
20150378180 | Blum et al. | Dec 2015 | A1 |
20160051360 | Tripathi | Feb 2016 | A1 |
20160060205 | He et al. | Mar 2016 | A1 |
20160062143 | Brennan et al. | Mar 2016 | A1 |
20160062145 | Brennan et al. | Mar 2016 | A1 |
20160085089 | Hillis et al. | Mar 2016 | A1 |
20160100938 | Bogaert et al. | Apr 2016 | A1 |
20160113727 | Tripathi et al. | Apr 2016 | A1 |
20160185910 | Bojkova | Jun 2016 | A1 |
20160209561 | DeMeio et al. | Jul 2016 | A1 |
20160216535 | Zhao | Jul 2016 | A1 |
20160220350 | Gerlach | Aug 2016 | A1 |
20160220352 | Choi et al. | Aug 2016 | A1 |
20160238758 | Turpen et al. | Aug 2016 | A1 |
20160243579 | Koenig, II et al. | Aug 2016 | A1 |
20160245967 | Koenig, II et al. | Aug 2016 | A1 |
20160279886 | Lynch et al. | Sep 2016 | A1 |
20160288157 | Lynch et al. | Oct 2016 | A1 |
20160296110 | Dorronsoro et al. | Oct 2016 | A1 |
20160299265 | Ghatak et al. | Oct 2016 | A1 |
20160302915 | Sayegh | Oct 2016 | A1 |
20160324628 | Gupta et al. | Nov 2016 | A1 |
20160324629 | Sandstedt et al. | Nov 2016 | A1 |
20160332995 | He et al. | Nov 2016 | A1 |
20160333262 | He et al. | Nov 2016 | A1 |
20160341978 | Schwiegerling | Nov 2016 | A1 |
20160363698 | Fan et al. | Dec 2016 | A1 |
20160377887 | Waite et al. | Dec 2016 | A1 |
20170002174 | Bhagwagar et al. | Jan 2017 | A1 |
20170009014 | Bhagwagar et al. | Jan 2017 | A1 |
20170035609 | Schachar et al. | Feb 2017 | A1 |
20170037173 | Saha et al. | Feb 2017 | A1 |
20170042665 | Currie et al. | Feb 2017 | A1 |
20170075140 | Hillis et al. | Mar 2017 | A1 |
20170105835 | Neuhann et al. | Apr 2017 | A1 |
20170123231 | Franklin et al. | May 2017 | A1 |
20170131570 | Thompson | May 2017 | A1 |
20170131571 | Waite et al. | May 2017 | A1 |
20170139230 | Ambler et al. | May 2017 | A1 |
20170146820 | Brennan et al. | May 2017 | A1 |
20170146822 | Wildsmith et al. | May 2017 | A1 |
20170153359 | Bojkova et al. | Jun 2017 | A1 |
20170209259 | Choi et al. | Jul 2017 | A1 |
20170213306 | Weeber et al. | Jul 2017 | A9 |
20170219846 | Ando | Aug 2017 | A1 |
20170224474 | Piers et al. | Aug 2017 | A1 |
20170227789 | Ando et al. | Aug 2017 | A1 |
20170235022 | Bojkova et al. | Aug 2017 | A1 |
20170239038 | Choi et al. | Aug 2017 | A1 |
20170252151 | Mackool | Sep 2017 | A1 |
20170258576 | Ghabra et al. | Sep 2017 | A1 |
20170261768 | Ambler et al. | Sep 2017 | A1 |
20170273778 | Zhao | Sep 2017 | A1 |
20170273779 | Zhao | Sep 2017 | A1 |
20170273780 | Zhao | Sep 2017 | A1 |
20170273781 | Zhao | Sep 2017 | A1 |
20170275534 | Reddy et al. | Sep 2017 | A1 |
20170276962 | Zhao | Sep 2017 | A1 |
20170290502 | Linder et al. | Oct 2017 | A1 |
20170290657 | Luque | Oct 2017 | A1 |
20170325937 | Weeber et al. | Nov 2017 | A1 |
20180015678 | Damodharan et al. | Jan 2018 | A1 |
20180024377 | Kumar et al. | Jan 2018 | A1 |
20180051037 | Deng et al. | Feb 2018 | A1 |
20180056615 | Turpen et al. | Mar 2018 | A1 |
20180086725 | Kumar et al. | Mar 2018 | A1 |
20180092739 | Pagnoulle et al. | Apr 2018 | A1 |
20180095190 | Frease et al. | Apr 2018 | A1 |
20180098694 | Schmeder | Apr 2018 | A1 |
20180125710 | Schachar et al. | May 2018 | A1 |
20180127653 | Kumar et al. | May 2018 | A1 |
20180147050 | Choi et al. | May 2018 | A1 |
20180147052 | Hong et al. | May 2018 | A1 |
20180164608 | Schmeder et al. | Jun 2018 | A1 |
20180171154 | Lu et al. | Jun 2018 | A1 |
20180180902 | Franklin et al. | Jun 2018 | A1 |
20180196284 | Schmeder et al. | Jul 2018 | A1 |
20180210330 | Tomasulo et al. | Jul 2018 | A1 |
20180243082 | Zheleznyak et al. | Aug 2018 | A1 |
20180249151 | Freeman et al. | Aug 2018 | A1 |
20180256317 | Bogaert et al. | Sep 2018 | A1 |
20180271741 | Dorronsoro et al. | Sep 2018 | A1 |
20180275428 | Ando | Sep 2018 | A1 |
20180289469 | Lux et al. | Oct 2018 | A1 |
20180290408 | Park et al. | Oct 2018 | A1 |
20180291007 | He et al. | Oct 2018 | A1 |
20180291008 | He et al. | Oct 2018 | A1 |
20180291009 | He et al. | Oct 2018 | A1 |
20180296324 | Zhang | Oct 2018 | A1 |
20180299599 | Kumar et al. | Oct 2018 | A1 |
20180299600 | Miller et al. | Oct 2018 | A1 |
20180303601 | Lux et al. | Oct 2018 | A1 |
20180311034 | Hong et al. | Nov 2018 | A1 |
20180321510 | Vetro | Nov 2018 | A1 |
20180329228 | Brennan et al. | Nov 2018 | A1 |
20180329229 | Brennan et al. | Nov 2018 | A1 |
20180329234 | Blum et al. | Nov 2018 | A1 |
20180344452 | Liao et al. | Dec 2018 | A1 |
20180348524 | Blum et al. | Dec 2018 | A1 |
20180348529 | Blum et al. | Dec 2018 | A1 |
20180368972 | Rosen et al. | Dec 2018 | A1 |
20190004221 | Weeber et al. | Jan 2019 | A1 |
20190004331 | Weeber et al. | Jan 2019 | A1 |
20190029808 | Piers et al. | Jan 2019 | A1 |
20190041664 | Ando | Feb 2019 | A1 |
20190047967 | Fromentin et al. | Feb 2019 | A1 |
20190053893 | Currie et al. | Feb 2019 | A1 |
20190107647 | Fromentin | Apr 2019 | A1 |
20190125523 | Barzilay | May 2019 | A1 |
20190133755 | Goldshleger et al. | May 2019 | A1 |
20190142576 | Goldshleger et al. | May 2019 | A1 |
20190142577 | Xie | May 2019 | A1 |
20190169438 | Fromentin et al. | Jun 2019 | A1 |
20190212473 | Fromentin et al. | Jul 2019 | A1 |
20190224000 | Choi et al. | Jul 2019 | A1 |
20190224001 | Choi et al. | Jul 2019 | A1 |
20190224803 | Masad et al. | Jul 2019 | A1 |
20190231518 | Sarver et al. | Aug 2019 | A1 |
20190247181 | Peyman | Aug 2019 | A1 |
20190254810 | Tiwari et al. | Aug 2019 | A1 |
20190290423 | Sayegh | Sep 2019 | A1 |
20190291128 | Zezinka et al. | Sep 2019 | A1 |
20190307556 | Sarver et al. | Oct 2019 | A1 |
20190307557 | De Carvalho et al. | Oct 2019 | A1 |
20190314148 | Lui | Oct 2019 | A1 |
20190321163 | Clamen et al. | Oct 2019 | A1 |
20190339545 | Schwiegerling | Nov 2019 | A1 |
20190343682 | Schachar et al. | Nov 2019 | A1 |
20190343683 | Zheleznyak et al. | Nov 2019 | A1 |
20190345286 | Valeri et al. | Nov 2019 | A1 |
20190353925 | Biskop et al. | Nov 2019 | A1 |
20190358027 | Hong et al. | Nov 2019 | A1 |
20190358919 | Kumar et al. | Nov 2019 | A1 |
20190361269 | Waite et al. | Nov 2019 | A1 |
20190365528 | Choi et al. | Dec 2019 | A1 |
20190374334 | Brady et al. | Dec 2019 | A1 |
20190375948 | Zheng | Dec 2019 | A1 |
20190375949 | Zheng et al. | Dec 2019 | A1 |
20190385342 | Freeman et al. | Dec 2019 | A1 |
20200009605 | Kumar et al. | Jan 2020 | A1 |
20200012110 | Blum et al. | Jan 2020 | A1 |
20200022840 | Kahook et al. | Jan 2020 | A1 |
20200030081 | Lux et al. | Jan 2020 | A1 |
20200033666 | Li | Jan 2020 | A1 |
20200048216 | Kumar et al. | Feb 2020 | A1 |
20200085569 | Kaschke et al. | Mar 2020 | A1 |
20200103571 | He et al. | Apr 2020 | A1 |
20200113736 | Bos et al. | Apr 2020 | A1 |
20200121450 | Sarver et al. | Apr 2020 | A1 |
20200122487 | Rodriguez et al. | Apr 2020 | A1 |
20200172798 | Stayshich et al. | Jun 2020 | A1 |
20200209649 | Holmstrom et al. | Jul 2020 | A1 |
20200218089 | Dubail et al. | Jul 2020 | A1 |
20200218093 | Blum et al. | Jul 2020 | A1 |
20200253722 | Choi et al. | Aug 2020 | A1 |
20200268506 | Zhao | Aug 2020 | A1 |
20200271958 | Zhao | Aug 2020 | A1 |
20200285075 | Zhao | Sep 2020 | A1 |
20200292847 | Wildsmith et al. | Sep 2020 | A1 |
20200292849 | Schmeder et al. | Sep 2020 | A1 |
20200326562 | Zhao | Oct 2020 | A1 |
20200333632 | Franklin et al. | Oct 2020 | A1 |
20200386913 | Fromentin et al. | Dec 2020 | A1 |
20200391457 | Damodharan et al. | Dec 2020 | A1 |
20200409178 | Zhao | Dec 2020 | A1 |
20210002415 | Zheng et al. | Jan 2021 | A1 |
20210003863 | Schwiegerling | Jan 2021 | A1 |
20210030532 | Hong et al. | Feb 2021 | A1 |
20210052368 | Smadja et al. | Feb 2021 | A1 |
20210055217 | Blackburn et al. | Feb 2021 | A1 |
20210059812 | Kontur et al. | Mar 2021 | A1 |
20210077251 | Barzilay | Mar 2021 | A1 |
20210079009 | Walters et al. | Mar 2021 | A1 |
20210080755 | Balasubramanian et al. | Mar 2021 | A1 |
20210116604 | Fromentin et al. | Apr 2021 | A1 |
20210169640 | Kaschke et al. | Jun 2021 | A1 |
20210177576 | Zheleznyak et al. | Jun 2021 | A1 |
20210177577 | Zheleznyak et al. | Jun 2021 | A1 |
20210177578 | Zheleznyak et al. | Jun 2021 | A1 |
20210177579 | Zheleznyak et al. | Jun 2021 | A1 |
20210196520 | Zheleznyak et al. | Jul 2021 | A1 |
20210220118 | Choi et al. | Jul 2021 | A1 |
20210228335 | Hong et al. | Jul 2021 | A1 |
20210228337 | Sarver et al. | Jul 2021 | A1 |
20210228338 | Choi et al. | Jul 2021 | A1 |
20210247626 | Zakharov et al. | Aug 2021 | A1 |
20210251718 | Tripathi | Aug 2021 | A1 |
20210298893 | Sarver et al. | Sep 2021 | A1 |
20210318556 | Shimojo et al. | Oct 2021 | A1 |
20210341760 | Burgos et al. | Nov 2021 | A1 |
Number | Date | Country |
---|---|---|
2007219322 | Oct 2007 | AU |
2007219323 | Oct 2007 | AU |
2008200665 | Mar 2008 | AU |
2011218693 | Sep 2011 | AU |
2012100457 | May 2012 | AU |
2012201991 | May 2012 | AU |
2013200699 | Feb 2013 | AU |
2013200702 | Feb 2013 | AU |
2013202083 | Apr 2013 | AU |
2015201867 | Apr 2013 | AU |
2017228616 | Apr 2018 | AU |
102016011774-7 | Dec 2017 | BR |
1275553 | Oct 1990 | CA |
2037556 | Sep 1991 | CA |
2388766 | Dec 2003 | CA |
2678025 | Aug 2009 | CA |
2824656 | Jul 2012 | CA |
1021990 | Sep 1993 | CN |
100543518 | Sep 2009 | CN |
108066046 | Nov 2019 | CN |
209808722 | Dec 2019 | CN |
209992764 | Jan 2020 | CN |
209992764 | Jan 2020 | CN |
280372 | Jan 1996 | CZ |
3924838 | Jul 1989 | DE |
29924922 | Sep 2006 | DE |
202016105180 | Oct 2017 | DE |
202016105181 | Oct 2017 | DE |
20 2019 000 174 | Apr 2019 | DE |
1063556 | Mar 2006 | EP |
2363426 | Sep 2011 | EP |
2548533 | Oct 2013 | EP |
3375410 | Sep 2018 | EP |
3415118 | Dec 2018 | EP |
3461460 | Apr 2019 | EP |
2208077 | May 2005 | ES |
2277705 | Jul 2008 | ES |
2038020 | Jul 1980 | GB |
2105866 | Mar 1983 | GB |
3814017 | May 1996 | JP |
3347514 | Nov 2002 | JP |
0133917 | Apr 1998 | KR |
10-1754196 | Jul 2017 | KR |
2008054 | Dec 2011 | NL |
2002456 | Nov 1993 | RU |
2012136016 | Feb 2014 | RU |
2682481 | Mar 2019 | RU |
I475278 | Mar 2015 | TW |
691733 | Feb 1992 | UA |
WO-9634365 | Oct 1996 | WO |
WO-9805279 | Feb 1998 | WO |
WO-9956671 | Nov 1999 | WO |
WO-0072051 | Nov 2000 | WO |
WO-02085245 | Oct 2002 | WO |
WO-2005006034 | Jan 2005 | WO |
WO-2006124016 | Nov 2006 | WO |
WO-2017006113 | Jan 2007 | WO |
WO-2007146265 | Dec 2007 | WO |
WO-2009076670 | Jun 2009 | WO |
WO-2011059430 | May 2011 | WO |
WO-2011060047 | May 2011 | WO |
WO-2011080730 | Jul 2011 | WO |
WO-2011107723 | Sep 2011 | WO |
WO-2011163668 | Dec 2011 | WO |
WO-2012083143 | Jun 2012 | WO |
WO-2012138426 | Oct 2012 | WO |
WO-2012167284 | Dec 2012 | WO |
WO-2012170066 | Dec 2012 | WO |
WO-2012170287 | Dec 2012 | WO |
WO-2013163532 | Oct 2013 | WO |
WO-2014120607 | Jan 2014 | WO |
WO-2014058315 | Apr 2014 | WO |
WO-2014065659 | May 2014 | WO |
WO-2014120601 | Aug 2014 | WO |
WO-2014140905 | Sep 2014 | WO |
WO-2014151543 | Sep 2014 | WO |
WO-2014152259 | Sep 2014 | WO |
WO 2015-008502 | Jun 2015 | WO |
WO-2015142559 | Sep 2015 | WO |
WO-2015142561 | Sep 2015 | WO |
WO-2015142562 | Sep 2015 | WO |
WO-2015159374 | Oct 2015 | WO |
WO-2018041098 | Mar 2018 | WO |
WO-2018167099 | Sep 2018 | WO |
WO-2018200717 | Nov 2018 | WO |
WO-2018219671 | Dec 2018 | WO |
WO-2018223150 | Dec 2018 | WO |
WO-2019001724 | Jan 2019 | WO |
WO-2019010874 | Jan 2019 | WO |
WO-2019219334 | Apr 2019 | WO |
WO-2019106031 | Jun 2019 | WO |
WO-2019129348 | Jul 2019 | WO |
WO-2019130030 | Jul 2019 | WO |
WO-2019130031 | Jul 2019 | WO |
WO-2019138411 | Jul 2019 | WO |
WO-2019173836 | Sep 2019 | WO |
2020011250 | Jan 2020 | WO |
WO-2020053864 | Mar 2020 | WO |
Entry |
---|
English Abstract of AU 2013200704-B2 published on Feb. 28, 2013. |
English Abstract of AU 2011204781-B2 published on Feb. 2, 2012. |
English Abstract of CA-3024244-A1 published on Sep. 10, 2019. |
English Abstract of CA-2717328-C published on Apr. 14, 2012. |
English Abstract of CN-209808722-U published on Dec. 20, 2019. |
English Abstract of ES-2277705-B2 published on Jul. 16, 2007. |
English Abstract of JP-3814017-B2 published on May 31, 1996. |
Garrard et al. (2008). “Design, Fabrication and Testing of Kinoform Lenses,” Proceedings of the ASPE 44: pp. 558-561. |
International Search Report and Written Opinion mailed Aug. 16, 2021, directed to International Application No. PCT/IB2021/054657; 11 pages. |
Moreno et al. (Jun. 1997). “High efficiency diffractive lenses: Deduction of kinoform profile,” Am. J. Phys. 65(6): 556-562. |
Riedl. “Diamond-turned diffractive optical elements for the infrared: suggestion for specification standardization and manufacturing remarks,” SPIE's 2020 International Symposium on Optical Science, Engineering, and Instrumentation, May 28, 2020, San Diego, California; pp. 257-268. |
Number | Date | Country | |
---|---|---|---|
20210369445 A1 | Dec 2021 | US |
Number | Date | Country | |
---|---|---|---|
63032892 | Jun 2020 | US |